Impact of psychiatric disorders on the quality of life of Brazilian HCV-infected patients

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 1, 2009, Pages 40-43

  Batista Neves, Susana ^a   Quarantini, Lucas C ^a,b,c   Galvão de Almeida, Amanda ^a   Cardeal, Maurício ^a   Lacerda, Acioly L ^b   Paraná, Raymundo ^a   De Oliveira, Irismar Reis ^a   Bressan, Rodrigo A ^b   Miranda Scippa, Angela ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Hospital Universitario   (Brazil)

Author keywords

HCV; Mental disorders; Quality of life

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT;

ADULT; ALCOHOLISM; AMINOTRANSFERASE BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; BLOOD TRANSFUSION; BRAZIL; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; FIBROSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW PLUS; MOOD DISORDER; PHYSICAL ACTIVITY; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SHORT FORM 36; SOCIOECONOMICS; SUBSTANCE ABUSE; TATTOOING; VIRUS TRANSMISSION; CROSS-SECTIONAL STUDY; HEALTH STATUS; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; BRAZIL; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 69249212527     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000100009     Document Type: Article

References (31)

1. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 2000; 75:18-9.
2. Seeff L.B., Hoofnagle J.H. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C: 2002. Hepatology 2002;36(suppl 1):S1-S2.
3. Foster G.R., Goldin R.D., Thomas H.C. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998;27:209-12.
4. Bonkovsky H.L., Woolley J.M., the Consensus Interferon Study Group. Reduction of health-related quality of life in HCV and improvement with interferon therapy. Hepatology 1999;29:264-70.
5. Fontana R.J., Moyer C.A., Sonnad S. et al. Comorbidities and quality of life in patients with interferon refractory chronic hepatitis C. Am J Gastroenterol 2001;96:170-8.
6. Rodger A.J., Jolley D., Thompson S.C. et al. The Impact of Diagnosis of Hepatitis C Virus on Quality of Life. Hepatology 1999;30:1299-301.
7. Dalgard O., Egeland A., Skaug K. et al. Health-related of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004;39:74-80.
8. Hussain K.B., Fontana R.J., Moyer C.A. et al. Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001;26:2737-44.
9. Younossi Z.M., Boparai N., Price L.L. et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001;96:2199-200.
10. Cordoba J., Flavia M., Jacas C. et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003;39:231-8.
11. Lim J.K., Cronkite R., Goldstein M.K., Cheung R.C. The impact of chronic hepatitis and comorbid psychiatric illnesses on healthrelated quality of life. J Clin Gastroenterol 2006;40:528-34.
12. Forton D.M., Taylor-Robinson S.D., Thomas H.C. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat 2003;10:66-81.
13. Batista-Neves S.C., Quarantini L.C., Galvão-Almeida A. et al. High frequency of unrecognized mental disorders in HCV-infected patients. Gen Hosp Psychiatry 2008;30:80-2.
14. Gallegos-Orozco J.F., Fuentes A.P., Argueta J.G. et al. Health related quality of life and depression in patients with chronic hepatitis C. Arch Med Res 2003;34:124-9.
15. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996;24:289-93.
16. Amorim P. Mini International Neuropsychiaric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras de Psiquiatr 2000;22:106-15.
17. Ciconelli R.M., Ferraz M.B., Santos W.S. et al. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida "Medical Outcome Study 36-Item Short Form Health Survey (SF-36)". Rev Bras Reumatol 1999;39:143-50.
18. Lauritsen J.M., Bruus M. EpiData (version 3). A comprehensive tool for validated entry and documentation of data. The EpiData Association, Odense Denmark, 2003-2004.
19. R Development Core Team (2006). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org. 2006.
20. Rowan P.J., Al-Jurdi R., Tavakoli Tabasi S., et al. Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol 2005;39:731-6.
21. Quarantini L.C., Miranda-Scippa A., Schinoni M.I., et al. Effect of amantadine on depressive symptoms in chronic hepatitis C patients treated with pegylated interferon: a randomized, controlled pilot study. Clin Neuropharmacol 2006;29:138-43.
22. Quarantini L.C., Miranda-Scippa A., Sampaio A.S., et al. Acute dystonia after injection of pegylated interferon alpha-2b. Mov Disorders 2007;22:747-8.
23. Quarantini L.C., Cruz S.C., Batista-Neves S.C., et al. Psychosis during Peginterferon-α2a and ribavirin therapy: case report. Braz J Infect Dis 2006;10:406-7.
24. Lotrich F.E., Rabinovitz M., Gironda P., Pollock B.G. Depression following pegylated interferon-alpha: Characteristics and vulnerability. J Psychosom Res 2007;63(2):131-5.
25. Miller R.E., Hiller J.E., Shaw D.R. Quality of life in HCV-infection: lack of association with ALT levels. Aust N Z J Public Health 2001;25:355-61.
26. Schwarzinger M., Dewedar S., Rekacewicz C., et al. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology 2004;40:1434-41.
27. Von Wagner M., Lee J.-H., Kronenberger B., et al. Impaired healthrelated quality of life in patients with chronic hepatitis C and persistently normal aminotransferase levels. J Viral Hepat 2006;13:828-834.
28. Teixeira M.C.D., Ribeiro M.F.G.S., Gayotto L.C.C., et al. Worse quality of life in volunteer blood donors with hepatitis C. Transfusion 2006;46:278-83.
29. Marchesini G., Bianch G., Amodio P., et al. Factors Associated With Poor Health-Related Quality of Life of Patients With Cirrhosis. Gastroenterology 2001;120:170-8.
30. Parana R., Lyra L., Trepo C. Intravenous vitamin complexes used in sporting activities and transmission of HCV in Brazil. Am J Gastroenterol 1999;94:857-8.
31. Quarantini L.C., Bressan R.A., Galvão-de Almeida A., et al. Incidence of psychiatric side effects during pegylated interferon alpha retreatment in nonresponder hepatitis C virus-infected patients. Liver International 2007;27:1098-102.